SCHEMBL29868053

SCHEMBL29868053

C1=CC=CC=CC=CC=CC=CC=CC=CNC=CC=CC=CC=CC=CC=CC=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22993 1.00
SCHEMBL30808383 1.00
SCHEMBL27879484 1.00
SCHEMBL28184335 1.00
SCHEMBL22434925 1.00
SCHEMBL18458273 1.00
Hydrochloric Acid SCHEMBL5741335 0.95
Charcoal, Activated SCHEMBL10756751 0.95
Bromide SCHEMBL10876007 0.95
Ammonia Solution, Strong SCHEMBL22117290 0.95

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4320101-A2 SYNTHESIS OF RAPAMYCIN ANALOG COMPOUNDS Revolution Medicines, Inc. (US) 2024-02-14 EP disclosed
EP-4281463-A1 RAPAMYCIN ANALOGS AND USES THEREOF JANSSEN Pharmaceutica NV (BE) 2023-11-29 EP disclosed
US-20230108125-A1 SMALL MOLECULE COMPOUNDS APERTOR PHARMACEUTICALS, INC. 2023-04-06 US disclosed
WO-2022216900-A2 SYNTHESIS OF RAPAMYCIN ANALOG COMPOUNDS Revolution Medicines, Inc. (US) 2022-10-13 WO disclosed
WO-2022159976-A1 RAPAMYCIN ANALOGS AND USES THEREOF ANAKURIA THERAPEUTICS, INC. (US) 2022-07-28 WO disclosed